ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.15%
US Dollar vs MXN
18.41389
0.00%
Brent Oil
84.815
0.04%
Bitcoin
64,857.61
-0.43%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. I MAB (IMAB)

  7. I MAB (IMAB) Noticias

IMAB I MAB

1.77
-0.05 (-2.75%)
18 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
I MAB IMAB NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.05 -2.75% 1.77 16:16:22
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.80 1.76 1.81 1.77 1.82
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/6/202406:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/6/202406:00PRNUSI-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical..
05/6/202406:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/6/202406:00PRNUSI-Mab Announces Collaboration with Bristol Myers Squibb to..
30/5/202416:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/5/202416:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202416:05GLOBEI-Mab Announces Encouraging Phase 1 Clinical Data of..
22/5/202406:00PRNUSI-Mab to Participate at the Jefferies Global Healthcare..
30/4/202406:00PRNUSI-MAB Filed 2023 Annual Report on Form 20-F
05/4/202406:00PRNUSI-Mab to Participate at the 23rd Annual Needham Virtual..
02/4/202415:01PRNUSI-Mab Announces Closing of the Divestiture of Business..
14/3/202416:00PRNUSI-Mab Reports Full Year 2023 Financial Results and Business..
09/2/202415:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202405:07EDGAR2Form 144 - Report of proposed sale of securities
07/2/202405:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/2/202405:00PRNUSI-Mab Signs Agreement to Divest its Assets and Business..
06/2/202419:55EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
06/2/202405:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202405:21EDGAR2Form 144 - Report of proposed sale of securities
02/1/202416:08DJNADRs Slump; FLJ Group Declines 21%
29/12/202305:12EDGAR2Form 144 - Report of proposed sale of securities
26/12/202305:22EDGAR2Form 144 - Report of proposed sale of securities
01/12/202313:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
16/11/202305:43EDGAR2Form 144 - Report of proposed sale of securities
06/11/202307:00PRNUSI-Mab Announces Participation at Jefferies and Piper..
02/11/202307:00PRNUSFelzartamab Granted Breakthrough Therapy Designation by U.S...
01/11/202307:00PRNUSI-Mab Announces Poster Presentations of 4-1BB Bispecific..
16/10/202307:00PRNUSI-Mab Announces Phase 1 Data of Givastomig at ESMO 2023
10/10/202310:04EDGAR2Form 144 - Report of proposed sale of securities
10/10/202307:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202307:00PRNUSI-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB..
29/9/202305:15EDGAR2Form 144 - Report of proposed sale of securities
22/9/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202307:00PRNUSI-Mab Announces Upcoming Participation at September..
17/8/202305:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202305:00PRNUSI-Mab Provides Mid-Year 2023 Financial Results, Business and..
08/8/202307:00PRNUSI-Mab to Report Mid-Year 2023 Financial Results, Business..
11/7/202305:17EDGAR2Form 144 - Report of proposed sale of securities
05/7/202307:39EDGAR2Form 144 - Report of proposed sale of securities
05/7/202307:34EDGAR2Form 144 - Report of proposed sale of securities
05/7/202307:22EDGAR2Form 144 - Report of proposed sale of securities
05/7/202307:00PRNUSI-Mab Announces Publication of Claudin18.2 x 4-1BB..
22/6/202307:00PRNUSI-Mab Announces the Appointment of Raj Kannan as CEO

Su Consulta Reciente

NASDAQ
IMAB
I MAB
NASDAQ
GRCL
Gracell Biotechnologies
BIT
P1EM28
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados